Transforming growth factor-β (TGF-β), an immunosuppressive cytokine, is also significantly elevated in high-grade gliomas and increased TGF-β activity confers poor prognosis in glioma patients [23,24]. This evidence concerns the gene TGFB1 and central nervous system cancer.